Outpatient medication
formulary. |
07/18/2024 |
Final File |
Amendment |
119.03 |
|
08/01/2024 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication
formulary. |
05/13/2024 |
Original File |
Amendment |
119.03 |
06/13/2024 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
Hearing Summary Report |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication
formulary. |
01/22/2024 |
Final File |
Amendment |
119.03 |
|
02/01/2024 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication
formulary. |
11/17/2023 |
Original File |
Amendment |
119.03 |
12/21/2023 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
Hearing Summary Report |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
07/20/2023 |
Final File |
Amendment |
119.03 |
|
08/01/2023 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
05/26/2023 |
Revise |
Amendment |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
05/16/2023 |
Revise |
Amendment |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
05/15/2023 |
Original File |
Amendment |
119.03 |
06/22/2023 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
01/09/2023 |
Final File |
Amendment |
119.03 |
|
02/01/2023 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
11/08/2022 |
Revise |
Amendment |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
11/03/2022 |
Original File |
Amendment |
119.03 |
12/08/2022 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
06/13/2022 |
Final File |
Amendment |
119.03 |
|
08/01/2022 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
04/07/2022 |
Original File |
Amendment |
119.03 |
05/17/2022 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
01/19/2022 |
Final File |
Amendment |
119.03 |
|
02/01/2022 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
11/12/2021 |
Original File |
Amendment |
119.03 |
12/20/2021 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
07/01/2021 |
Final File |
Amendment |
119.03 |
|
08/01/2021 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
04/26/2021 |
Original File |
Amendment |
119.03 |
06/03/2021 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
Hearing Summary Report |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
03/19/2021 |
Final File |
Amendment |
119.03 |
|
04/01/2021 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
01/12/2021 |
Original File |
Amendment |
119.03 |
02/19/2021 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
08/07/2020 |
Final File |
Amendment |
119.03 |
|
09/01/2020 |
|
Y |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
06/01/2020 |
Revise |
Amendment |
119.03 |
|
|
|
Y |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
05/29/2020 |
Original File |
Amendment |
119.03 |
07/01/2020 |
|
|
Y |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
05/20/2019 |
Final File |
Amendment |
119.03 |
|
06/01/2019 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
03/15/2019 |
Original File |
Amendment |
119.03 |
04/23/2019 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
12/31/2018 |
Final File |
Amendment |
119.03 |
|
01/10/2019 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
10/11/2018 |
Original File |
Amendment |
119.03 |
11/20/2018 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
Hearing Summary Report |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
04/20/2018 |
Final File |
Amendment |
119.03 |
|
05/01/2018 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
02/13/2018 |
Original File |
Amendment |
119.03 |
03/22/2018 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
09/18/2017 |
Final File |
Amendment |
119.03 |
|
10/01/2017 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
07/14/2017 |
Original File |
Amendment |
119.03 |
08/14/2017 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
12/22/2016 |
Final File |
Amendment |
119.03 |
|
01/01/2017 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
10/27/2016 |
Revise |
Amendment |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
10/17/2016 |
Original File |
Amendment |
119.03 |
11/21/2016 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
11/20/2015 |
Final File |
Amendment |
119.03 |
|
12/01/2015 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
09/24/2015 |
Revise |
Amendment |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
09/14/2015 |
Original File |
Amendment |
119.03 |
10/21/2015 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
04/16/2015 |
Final File |
Amendment |
119.03 |
|
05/01/2015 |
|
Y |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
02/09/2015 |
Revise |
Amendment |
119.03 |
03/20/2015 |
|
|
Y |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
02/09/2015 |
Original File |
Amendment |
119.03 |
03/24/2015 |
|
|
Y |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
08/15/2014 |
Final File |
Amendment |
119.03 |
|
09/01/2014 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
06/10/2014 |
Original File |
Amendment |
119.03 |
07/16/2014 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
12/23/2013 |
Final File |
Amendment |
119.03 |
|
01/02/2014 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
11/21/2013 |
Refile |
Amendment |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
11/21/2013 |
Withdraw Final |
Amendment |
119.03 |
|
|
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
11/21/2013 |
Final File |
Amendment |
119.03 |
|
12/01/2013 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
09/16/2013 |
Original File |
Amendment |
119.03 |
10/25/2013 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
03/14/2013 |
Final File |
Amendment |
119.03 |
|
04/01/2013 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
01/07/2013 |
Original File |
Amendment |
119.03 |
02/15/2013 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
08/20/2012 |
Final File |
Amendment |
119.03 |
|
09/01/2012 |
|
N |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
06/14/2012 |
Original File |
Amendment |
119.03 |
07/23/2012 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
CSI Business Impact Analysis |
|
CSI Recommendation |
|
CSI Agency Memorandum of Response |
|
|
Outpatient medication formulary. |
01/10/2012 |
Final File |
Amendment |
119.03 |
|
02/01/2012 |
|
N |
|
Rule Body |
|
Appendices |
|
|
Outpatient medication formulary. |
11/01/2011 |
Original File |
Amendment |
119.03 |
12/09/2011 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
|
Outpatient Medication Formulary . |
08/19/2011 |
Final File |
New |
119.03 |
|
09/01/2011 |
|
N |
|
Rule Body |
|
Appendices |
|
|
Outpatient Medication Formulary . |
06/17/2011 |
Revise |
New |
119.03 |
|
|
|
N |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
|
Outpatient Medication Formulary . |
06/07/2011 |
Original File |
New |
119.03 |
07/14/2011 |
|
|
N |
|
Public Notice |
|
RSFA Analysis |
|
Rule Body |
|
Appendices |
|
|